Stanford COVID-19 Research: Neera Ahuja

Along with collaborator Kari Nadeau, Clinical Professor Neera Ahuja is conducting a randomized, double-blind, placebo-controlled phase 3 trial to evaluate the safety and efficacy of the antiviral drug Remdesivir in hospitalized adult patients diagnosed with COVID-19. For more Stanford COVID-19 research:


SyncID: MB01KYUH7PSPQLK